CN101502539A - Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation - Google Patents

Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation Download PDF

Info

Publication number
CN101502539A
CN101502539A CNA2009100740005A CN200910074000A CN101502539A CN 101502539 A CN101502539 A CN 101502539A CN A2009100740005 A CNA2009100740005 A CN A2009100740005A CN 200910074000 A CN200910074000 A CN 200910074000A CN 101502539 A CN101502539 A CN 101502539A
Authority
CN
China
Prior art keywords
preparation
folium ginkgo
cyclodextrin inclusion
ginkgo biloba
biloba extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2009100740005A
Other languages
Chinese (zh)
Other versions
CN101502539B (en
Inventor
刘近荣
韩雪锋
沈达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANXI ZHENDONG TAISHENG PHARMACEUTICAL CO Ltd
Original Assignee
SHANXI ZHENDONG TAISHENG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANXI ZHENDONG TAISHENG PHARMACEUTICAL CO Ltd filed Critical SHANXI ZHENDONG TAISHENG PHARMACEUTICAL CO Ltd
Priority to CN2009100740005A priority Critical patent/CN101502539B/en
Publication of CN101502539A publication Critical patent/CN101502539A/en
Application granted granted Critical
Publication of CN101502539B publication Critical patent/CN101502539B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a preparation prepared by ginkgo biloba extract, in particular to a ginkgo biloba extract cyclodextrin inclusion compound and a preparation method of the preparation. The problems of poor solubility, low dissolution rate, poor storage performance and the like in a variety of preparations of the ginkgo biloba extract in the prior art can be solved. The method comprises the steps of adding water in 2-hydroxypropyl-beta-cyclodextrin, heating and dissolving to prepare 2-hydroxypropyl-beta-cyclodextrin solution, then using 95 percent ethanol for dissolving the ginkgo biloba extract, dripping ginkgo biloba extract-ethanol solution to the 2-hydroxypropyl-beta-cyclodextrin solution under the stirring state, lasting the process for 1 hour, stopping heating after completing the dripping, continuously stirring for 1-3 hours; stopping stirring, standing reaction liquid and filtering for preparation. The ginkgo biloba extract 2-hydroxypropyl-beta-cyclodextrin inclusion compound and a variety of preparations can greatly improve the problem of small solubility of the ginkgo biloba extract in the water and improve the stability of the ginkgo biloba extract in the water.

Description

The preparation method of ginkgo leaf extract cyclodextrin inclusion compound and preparation
Technical field
The present invention relates to a kind of preparation of Folium Ginkgo extract preparation, be specially the preparation method of a kind of ginkgo leaf extract cyclodextrin inclusion compound and preparation.
Background technology
Contain effective ingredient such as a large amount of ginkgetins, Ginkgo biloba terpenes lactone in the Folium Ginkgo, can improve human body respiration, improve sleep quality, life-time service can prevent and treat cardiovascular disease. prevent hypertension that the adult causes because of the vessel aging, apoplexy, diabetes etc., can make the adult especially keep the natural materials of normal cardiac output and normal nervous function period, make the people keep normal cell life cycle as far as possible person in middle and old age.
Modern study is found, flavone compound is for improving the heart, cerebral blood circulation in the Folium Ginkgo extract, reduce serum cholesterol, lax bronchial smooth muscle has better curative effect, and treatment coronary atherosclerotic heart disease, myocardial infarction, expansion of cerebral vascular, cerebral blood flow increasing amount, treatment ischemic encephalopathy are had good effect.The Folium Ginkgo terpene lactones compounds is the strongest PAF (platelet activating factor) antagonist of activity that extracts from natural drug, can stop the damage that causes after the cerebral ischemia to the central nervous system, can obviously improve cerebral ischemic condition.Bilobalide can anticoagulant, and blood viscosity lowering improves ischemia patient's microcirculation, reduces thrombosis, also has antiallergic, antiinflammatory, Antishock function simultaneously, and the rejection of ischemic injuries and organ transplantation is had protective effect.
The preparation that contains Folium Ginkgo extract at present mainly contains tablet, capsule, small-volume injection, the ubiquity water solublity is bad in numerous dosage forms, with precipitation problem such as produce, darken is arranged in the storage process, also have the low problem of dissolution for tablet and capsule.The present invention adopts the 2-HP-that Folium Ginkgo extract is carried out enclose, cooperate each dosage form to add corresponding auxiliary material again and make preparation, thereby improved the dissolubility of preparation in water that contains Folium Ginkgo extract greatly, made the physiologically active of effective ingredient in the product and physicochemical property reliable and stable.
Summary of the invention
The present invention is problem such as the poor solubility, the dissolution that exist in the various preparations of the Folium Ginkgo extract that exists in the prior art are low, poor storage performance and the preparation method of a kind of ginkgo leaf extract cyclodextrin inclusion compound and preparation thereof is provided in order to solve.
The present invention is realized by following technical scheme, a kind of ginkgo leaf extract cyclodextrin inclusion compound is prepared by following method, the 2-HP-added water and be heated to 50-60 ℃ make its whole dissolvings, make 2-HP-solution, mass concentration is 5-10%; Folium Ginkgo extract is used 95% dissolve with ethanol again, under stirring the Folium Ginkgo extract alcoholic solution is added drop-wise in the 2-HP-solution, process continues 1 hour, stops heating after adding, and continues to stir and keeps 1-3 hour; Stop to stir reactant liquor is left standstill, filters promptly.Stir and adopt electric mixing device, rotating speed is 40-80 rev/min, and the mass ratio that feeds intake of Folium Ginkgo extract and 2-HP-is 1:2-4.
Method for preparing obtains the ginkgo leaf extract cyclodextrin inclusion compound pharmaceutical solutions, this pharmaceutical solutions and different pharmaceutic adjuvant preparations, adopt corresponding technology can be prepared into multiple dosage form, as solid preparation (comprising tablet, capsule, granule etc.), injection (comprising small-volume injection, bulk capacity injection, aseptic powder injection, freeze-dried powder etc.).
The present invention has carried out a large amount of tests in inclusion method, influence factor, stability, the safety of research cyclodextrin and Folium Ginkgo extract, now the research situation is summarized as follows:
Determining of cyclodextrin: we from numerous cyclodextrin products, by analysis, screening, test, selected alpha-cyclodextrin, beta-schardinger dextrin-, gamma-cyclodextrin, 2-HP-as main research to picture.Its dissolubility is as shown in the table:
Table 1 alpha-cyclodextrin, beta-schardinger dextrin-, gamma-cyclodextrin, 2-HP-dissolubility
Title Alpha-cyclodextrin Beta-schardinger dextrin- Gamma-cyclodextrin The 2-HP-
Dissolubility (g/L, 25 ℃) 145 18.5 232 750
As can be seen, the beta-schardinger dextrin-dissolubility is minimum from the dissolubility of alpha-cyclodextrin, beta-schardinger dextrin-, gamma-cyclodextrin, 2-HP-, and the alpha-cyclodextrin supply is less, be difficult to obtain, gamma-cyclodextrin is comparatively desirable, but price is more expensive, and production application is less.Therefore we have selected the 2-HP-to carry out researchs such as inclusion method as the raw material that carries out enclose with Folium Ginkgo extract.
Inclusion method research: the method for cyclodextrin inclusion compound is a lot, and we are actual from producing, and adopts paddling process, supercritical ultrasonics technology, polishing, and three kinds of inclusion methods have been carried out odds.
Paddling process is to use electric mixing device, the 2-HP-added water and be heated to 50-60 ℃ make whole dissolvings, with Folium Ginkgo extract 95% dissolve with ethanol, slowly splash in the 2-HP-solution and stirred 1 hour, stop heating, continue to stir and kept 4 hours, reactant liquor leaves standstill, filters, is drying to obtain.
Supercritical ultrasonics technology is earlier the 2-HP-to be added the water heating to make whole dissolvings, with Folium Ginkgo extract 95% dissolve with ethanol, the two is mixed obtain mixing material, used the ultrasonic disruption instrument then ultrasonic 5 minutes, intensity 14, replace mixing power, stop ultrasonic reactant liquor being left standstill, filter, is drying to obtain.
Polishing is that the 2-HP-is placed mortar, add suitable quantity of water moistening after, add the Folium Ginkgo extract alcoholic solution, fully mixed grinding becomes pasty state, and constantly adds water make dissolving in mortar, and reactant liquor is left standstill, filters, is drying to obtain.
Result of the test, ginkgetin and lactone content in the clathrate that the mensuration distinct methods makes, paddling process〉ultrasonic method〉polishing.Productivity ratio, polishing〉ultrasonic method paddling process.Polishing output is the highest, but drug content is minimum, checks that the 2-HP-that has does not form clathrate, and it is the highest that the clathrate that paddling process makes contains the principal agent amount, and after the balance, we have selected to use paddling process.
Optimum charging ratio is selected: with different rate of charges, adopt paddling process to carry out enclose, with Folium Ginkgo extract: the 2-HP-is 1:1,1:2,1:4,1:8,1:10,1:20 carries out enclose, survey ginkgetin and lactone content in the clathrate, the result is with 1:2, the rate of charge of 1:4 is more suitable, 1:1 feeds intake, it is lower to record content, illustrate that enclose is incomplete, 1:8,1:10,1:20 feeds intake and 1:2,1:4 relatively, content differs and is not clearly, and illustrating feeds intake between the 1:2-1:4 can reach best enclose effect, and changes of contents is not obvious along with the increase of ingredient proportion, declaratives 2-HP-is excessive for feeding intake, have neither part nor lot in enclose, invalid composition, so we have determined that the optimum charging ratio of Folium Ginkgo extract and 2-HP-is 1:2-4.Ginkgetin and lactone amount and inclusion rate are as shown in the table in the different rate of charge clathrates.
Ginkgetin and lactone content and inclusion rate in the different rate of charge clathrates of table 2
Figure A200910074000D00061
The selection of mixing time: paddling process also has much relations with mixing time, we are that 1:2 feeds intake by Folium Ginkgo extract and 2-HP-, adopt stirring means to prepare clathrate, stir 1 respectively, 2,4,5,10 hours, make clathrate and survey ginkgetin and lactone content, the result shows to stir 2-4 hour for well, bilobalide content was low in 1 hour, illustrate and do not have abundant enclose, 5,10 hours content and 2,4 hours content differs very little, illustrates that Folium Ginkgo extract prepares clathrate with stirring means and can finish enclose in 2-4 hour in stirring.
Preparation technology determines: so we have determined that Folium Ginkgo extract and 2-HP-prepare the preparation technology of clathrate: the 2-HP-is added water and be heated to 50-60 ℃ and make its whole dissolvings, make 2-HP-solution, mass concentration is 5-10%; Folium Ginkgo extract is used 95% dissolve with ethanol again, under stirring the Folium Ginkgo extract alcoholic solution is added drop-wise in the 2-HP-solution, process continues 1 hour, stops heating after adding, and continues to stir and keeps 1-3 hour; Stop to stir reactant liquor is left standstill, filters promptly.Stir and adopt electric mixing device, rotating speed is 40-80 rev/min, and the mass ratio that feeds intake of Folium Ginkgo extract and 2-HP-is 1:2-4.
The research of preparation technology's repeatability: we adopt above-mentioned definite preparation technology, with Folium Ginkgo extract and 2-HP-is that 1:2 feeds intake, electronic stirring 4 hours, 60 rev/mins of rotating speeds, 6 batches of clathrates have been prepared, productive rate, active constituent content to clathrate are analyzed, and the result shows that this technology repeatability is good, illustrate that preparation condition is suitable, reliable.Ginkgetin and bilobalide amount and inclusion rate measurement result are as follows in the clathrate.
Ginkgetin and lactone content and inclusion rate in table 3 clathrate
Figure A200910074000D00071
Clathrate and pharmaceutic adjuvant preparation that the present invention adopts above-mentioned preparation method to obtain, and adopt certain method can be prepared into multiple dosage form, as solid preparation (comprising tablet, capsule, granule etc.), injection (comprising small-volume injection, bulk capacity injection, aseptic powder injection, freeze-dried powder etc.).When being used to prepare small-volume injection, bulk capacity injection and lyophilized injectable powder, directly prepare drying-free after can filtering, filtration can be adopted sucking filtration, ultrafiltration or filter with the filter of 0.22 μ m.To carry out drying when being used to prepare solid preparation, injectable powder, dry employing vacuum decompression drying or lyophilization.
The present invention prepares the method for small-volume injection: at first 2-4 part 2-HP-is added the water heating and make whole dissolvings, make 2-HP-solution; Secondly with 1 part of Folium Ginkgo extract 95% dissolve with ethanol, slowly splash in the 2-HP-solution and stirred 1 hour; Stop heating, continue to stir and kept 1-3 hour; Stir and adopt electric mixing device, rotating speed is 40-80 rev/min.Stop to stir reactant liquor was left standstill 2 hours, the filter with 0.22 μ m to the room temperature filters, and adds an amount of medicinal charcoal, adds and prepares required water for injection, and heated and boiled 30 minutes is filtered after the cooling, with the PH regulator pH value is adjusted to 4.5-5.8.After being filtered to clarification, fill is in the cillin bottle of 10ml sterilization, and lid is rolled in lyophilization, that is, or embedding seals in the 10ml ampoule, sterilizes, promptly.
The safety research of injection: injection is the highest to security requirement in multiple dosage form, therefore we make injection with above-mentioned preparation method and have carried out zoopery, by various dose, different way of administration is a laboratory animal with mice, rat, and maximum dose level intraperitoneal and intravenously administrable have reached 10.0g/kg, the behavior of observation animal, dietary habit, nephrotoxicity etc. after the administration, all have no adverse effect, vital sign is normal, illustrates that the injection that this product makes is safe.Its experimental result is as shown in the table.
Table 4 zoopery result
Figure A200910074000D00081
The stability study of injection: in order to verify the stability of the prepared injection of the present invention, we select same batch of injection to test under 60 ℃, 18-26 ℃, 0-4 ℃, 4576lx illumination condition.Result such as following table: table 5 injection stability test result
Condition Time (my god) Clarity Differentiate The content of ginkgetin (mg/ml) The content of bilobalide (mg/ml)
60℃ 0 30 90 180 Clarification clarification clarification clarification Positive 0.847 0.847 0.845 0.842 0.223 0.222 0.220 0.218
18-26℃ 0 30 90 180 Clarification clarification clarification clarification Positive 0.848 0.847 0.844 0.842 0.224 0.223 0.221 0.220
0-4℃ 0 30 90 180 Clarification clarification clarification clarification Positive 0.850 0.848 0.847 0.845 0.224 0.223 0.222 0.221
4576lx 0 30 90 180 Clarification clarification clarification clarification Positive 0.852 0.850 0.846 0.843 0.227 0.225 0.223 0.221
Through experimental results show that repeatedly: Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion, improved the very little problem of Folium Ginkgo extract dissolubility in water greatly, and improved the stability of Folium Ginkgo extract in water when making injection.
The specific embodiment
Embodiment 1
Preparation Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion tablet
Folium Ginkgo extract 10g
95% ethanol 10ml
2-HP-20g
Starch 80g
Carboxymethyl starch sodium 10g
10% gelatinized corn starch 200g
Magnesium stearate 5g
Getting 2-HP-20g adds 380g water and is heated to 50 ℃ and make its dissolving, make 2-HP-solution, get Folium Ginkgo extract 10g and be dissolved in the 10ml95% ethanol, then the Folium Ginkgo extract alcoholic solution is slowly splashed in the 2-HP-solution and continue and stirred 1 hour; Stop heating, continue to stir and kept 1-3 hour, stir and adopt electric mixing device, rotating speed is 40-80 rev/min; Stop to stir reactant liquor is left standstill, filter, the vacuum decompression drying promptly gets Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion.
Get 10g Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion, add 80g starch, the 10g carboxymethyl starch sodium, with blender with its mix homogeneously, and add 10% gelatinized corn starch 200g, make soft material, cross 16 mesh sieves and granulate 65-75 ℃ of oven dry, cross 18 mesh sieve granulate, add 5g magnesium stearate tabletting, make 225, get tablet.
Embodiment 2
Preparation Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion granule
Folium Ginkgo extract 10g
95% ethanol 10ml
2-HP-40g
Starch 200g
Icing Sugar 200g
20% gelatinized corn starch 200g
Getting 2-HP-40g adds 360g water and is heated to 55 ℃ and make its dissolving, make 2-HP-solution, get Folium Ginkgo extract 10g and be dissolved in the 10ml95% ethanol, then the Folium Ginkgo extract alcoholic solution is slowly splashed in the 2-HP-solution and stirred 1 hour; Stop heating, continue to stir and kept 1-3 hour, stir and adopt electric mixing device, rotating speed is 40-80 rev/min; Stop to stir reactant liquor is left standstill, filter, the vacuum decompression drying promptly gets Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion.
Get 10g Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion, add 200g starch, the 140g Icing Sugar with its mix homogeneously, and adds 20% gelatinized corn starch 200g with blender, makes soft material, crosses 14 mesh sieves and granulates.The 60g Icing Sugar is made 30% syrup, be sprayed on particle surface, 16 mesh sieve granulate are crossed in 65-75 ℃ of oven dry, and the packing of machine bag is made 225 bags, gets granule.
Embodiment 3
Preparation Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion small-volume injection
Folium Ginkgo extract 10g
95% ethanol 10ml
2-HP-30g
Thiourea 2.5g
Medicinal charcoal 2.5g
Water for injection 2400ml
At first the 30g2-HP-is added 350g water and be heated to 60 ℃ and make whole dissolvings, make 2-HP-solution; Secondly the 10g Folium Ginkgo extract is dissolved with 95% ethanol 10ml, slowly splash in the 2-HP-solution and stirred 1 hour; Stop heating, continue to stir and kept 1-3 hour; Stir and adopt electric mixing device, rotating speed is 40-80 rev/min.Stop to stir reactant liquor was left standstill 2 hours.Getting 100ml Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion to the room temperature filters with the filter of 0.22 μ m, add the 2.5g thiourea, 2.5g medicinal charcoal, add water for injection 1000ml, heated and boiled 30 minutes, filter after the cooling, add residue water for injection, pH value is adjusted to 4.5-5.8 with the PH regulator to 2500ml.After being filtered to clarification, embedding is made 250, promptly in the 10ml ampoule.
Embodiment 4
Preparation Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion bulk capacity injection
Folium Ginkgo extract 10g
95% ethanol 10ml
2-HP-20g
Sodium chloride 22.5g
Thiourea 2.5g
Medicinal charcoal 2.5g
Water for injection 2400ml
At first the 20g2-HP-is added 180g water and be heated to 50 ℃ and make whole dissolvings, make 2-HP-solution; Secondly the 10g Folium Ginkgo extract is dissolved with 95% ethanol 10ml, slowly splash in the 2-HP-solution and stirred 1 hour; Stop heating, continue to stir and kept 1-3 hour; Stir and adopt electric mixing device, rotating speed is 40-80 rev/min.Stop to stir reactant liquor was left standstill 2 hours.Getting 100ml Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion to the room temperature filters with the filter of 0.22 μ m, add the 2.5g thiourea, 2.5g medicinal charcoal, add water for injection 1000ml, heated and boiled 30 minutes, filter after the cooling, add residue water for injection, pH value is adjusted to 4.5-5.8 with the PH regulator to 2500ml.After being filtered to clarification, embedding is made 25 bottles, promptly in the 100ml infusion bottle.
Embodiment 5
Preparation Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion freezing-dried powder injection
Folium Ginkgo extract 10g
95% ethanol 10ml
2-HP-40g
Medicinal charcoal 2.5g
Water for injection 1580ml
At first the 40g2-HP-is added 360g water and be heated to 60 ℃ and make whole dissolvings, make 2-HP-solution; Secondly the 10g Folium Ginkgo extract is dissolved with 95% ethanol 10ml, slowly splash in the 2-HP-solution and stirred 1 hour; Stop heating, continue to stir and kept 1-3 hour; Stir and adopt electric mixing device, rotating speed is 40-80 rev/min.Stop to stir reactant liquor was left standstill 2 hours.Getting 100ml Folium Ginkgo extract 2-hydroxypropyl-beta-cyclodextrin inclusion to the room temperature filters with the filter of 0.22 μ m, 2.5g medicinal charcoal, add water for injection 1000ml, heated and boiled 30 minutes, filter after the cooling, add residue water for injection to 1680ml, pH value is adjusted to 4.5-5.8 with the PH regulator.After being filtered to clarification, sterile filling is in the cillin bottle of 10ml sterilization, and every 3.7ml makes 450, and lyophilization 30-48 hour, lid was rolled in tamponade, promptly.

Claims (3)

1, a kind of ginkgo leaf extract cyclodextrin inclusion compound is characterized in that: be by the 2-HP-being added water and be heated to 50-60 ℃ and make its whole dissolvings of following method preparation, make 2-HP-solution, mass concentration is 5-10%; Folium Ginkgo extract is used 95% dissolve with ethanol again, under stirring the Folium Ginkgo extract alcoholic solution is added drop-wise in the 2-HP-solution, process continues 1 hour, stops heating after adding, and continues to stir and keeps 1-3 hour; Stop to stir reactant liquor is left standstill, filters promptly.
2, ginkgo leaf extract cyclodextrin inclusion compound according to claim 1 is characterized in that: stir and adopt electric mixing device, rotating speed is 40-80 rev/min, and the mass ratio that feeds intake of Folium Ginkgo extract and 2-HP-is 1:2-4.
3, ginkgo leaf extract cyclodextrin inclusion compound according to claim 1 is characterized in that: its dosage form is tablet, capsule, granule, small-volume injection, bulk capacity injection, aseptic powder injection, freeze-dried powder.
CN2009100740005A 2009-03-21 2009-03-21 Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation Active CN101502539B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100740005A CN101502539B (en) 2009-03-21 2009-03-21 Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100740005A CN101502539B (en) 2009-03-21 2009-03-21 Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation

Publications (2)

Publication Number Publication Date
CN101502539A true CN101502539A (en) 2009-08-12
CN101502539B CN101502539B (en) 2011-05-11

Family

ID=40975000

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100740005A Active CN101502539B (en) 2009-03-21 2009-03-21 Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation

Country Status (1)

Country Link
CN (1) CN101502539B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103877130A (en) * 2013-09-17 2014-06-25 狄留庆 Chinese medicinal composition for treating ischemic cerebral paralysis, application thereof to preparation of oral preparation and preparation of Chinese medicinal composition
CN107261157A (en) * 2017-06-14 2017-10-20 苏州大学 Inclusion compound of blueberry leaf melanin and its preparation method and application
CN107773763A (en) * 2016-08-25 2018-03-09 江苏康缘药业股份有限公司 Bilobalide K beta cyclodextrin clathrate and preparation method thereof
CN109432440A (en) * 2018-11-30 2019-03-08 佛山科学技术学院 A kind of praziquantel hydroxypropyl cyclodextrin inclusion and its preparation method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1233369C (en) * 2003-06-23 2005-12-28 江苏扬子江药业集团有限公司 Ginkgo leaf powder for injection and its prepn
CN1232251C (en) * 2004-01-14 2005-12-21 江苏康缘药业股份有限公司 Gingko lactone powder injection and its preparation method

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103877130A (en) * 2013-09-17 2014-06-25 狄留庆 Chinese medicinal composition for treating ischemic cerebral paralysis, application thereof to preparation of oral preparation and preparation of Chinese medicinal composition
CN107773763A (en) * 2016-08-25 2018-03-09 江苏康缘药业股份有限公司 Bilobalide K beta cyclodextrin clathrate and preparation method thereof
CN107261157A (en) * 2017-06-14 2017-10-20 苏州大学 Inclusion compound of blueberry leaf melanin and its preparation method and application
CN107261157B (en) * 2017-06-14 2020-01-10 苏州大学 Inclusion compound of vaccinium bracteatum leaf melanin and preparation method and application thereof
CN109432440A (en) * 2018-11-30 2019-03-08 佛山科学技术学院 A kind of praziquantel hydroxypropyl cyclodextrin inclusion and its preparation method and application
CN109432440B (en) * 2018-11-30 2022-04-26 佛山科学技术学院 Praziquantel hydroxypropyl cyclodextrin inclusion compound and preparation method and application thereof

Also Published As

Publication number Publication date
CN101502539B (en) 2011-05-11

Similar Documents

Publication Publication Date Title
CN102349963A (en) Health care product for preventing microthrombus from forming and preparation method thereof
CN101502539B (en) Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation
CN106723015A (en) A kind of health food and its preparation technology with antifatigue and anti-oxidation function
CN108157971A (en) A kind of chitosan oligosaccharide liquid oral medicine and preparation method thereof
JPH06237735A (en) Food having hypoglycemic action
CN1775216A (en) New formulation oxaliplatin liposome
CN107136269B (en) Cyclocarya paliurus and bitter gourd blood sugar reducing tea and preparation method thereof
CN101019884A (en) Compound coenzyme Q10 medicine prepn and its prepn process and application
CN101744986A (en) Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof
CN108391772A (en) A kind of preparation method of gingko functional beverage
CN101019846A (en) Prepn of capsule containing pyruvic acid and its salt
CN1444948B (en) Liposome of Breviscapine and its preparing method
CN101744991B (en) Single extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
CN108185343A (en) A kind of instant compound meal replacement powder low in calories and preparation method thereof
CN101744989B (en) Method for extracting schisandra chinensis, ginseng and dwarf lilyturf root and preparation thereof
CN111265627B (en) Sea cucumber polysaccharide composition for regulating intestinal flora and preparation method and application thereof
CN1857410A (en) Chinese medicine for treating neuorsis and its preparing method
CN106074398A (en) A kind of freeze dried lentinan holoside powder injecta and preparation method thereof
CN1965919A (en) Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof
CN101744996A (en) Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
CN1634036A (en) Andrographolide soft capsule formulation and preparation method thereof
CN1110179A (en) Auxiliary material-oligosaccharlde for oral drug or solid drink
CN104095178A (en) Composition used for assistant reduction of blood sugar
CN107308198A (en) A kind of treat loses paralysis, the Chinese medicine preparation of coronary heart disease after ischemic cerebrovascular disease and bleeding
CN100508788C (en) Health food for diabetic patient and preparing method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant